1 ml semaglutide Flex-Dose Injectable 2.5 mg/mL Semaglutide for weight loss |

doi: 10.1016/S2213-2600(19)30172-9 125 GhebremedhinASalamABAdu-AddaiBNoonanSStrattonRAhmedMSUet al

290 A phase I/II trial is currently underway to evaluate the efficacy of JHU-083 in advanced solid tumors (NCT04471415) (Table 1)

Tirzepatide is administered as a once-weekly subcutaneous injection, with dosing typically initiated at 2.5 mg and increased by 2.5 mg every 4 weeks up to a maintenance dose of 5-15 mg based on tolerability and therapeutic response

Cycle Length: Research protocols vary, but use is generally suggested for 3-5 days weekly or continuously for 4-8 weeks to achieve normalization of sleep architecture